SHR-1918 / Jiangsu Hengrui Pharma  >>  Phase 2
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SHR-1918 / Jiangsu Hengrui Pharma
NCT06471218: Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia

Not yet recruiting
2
42
RoW
SHR-1918; SHR-1918 Placebo
Beijing Suncadia Pharmaceuticals Co., Ltd
Hyperlipidemia
04/25
06/25
NCT06009393: Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia

Not yet recruiting
2
20
NA
SHR-1918
Beijing Suncadia Pharmaceuticals Co., Ltd
Homozygous Familial Hypercholesterolemia
06/24
08/24
NCT06109831: Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic

Active, not recruiting
2
335
RoW
SHR-1918, SHR-1918 placebo
Beijing Suncadia Pharmaceuticals Co., Ltd
Hyperlipidemic
10/24
09/25

Download Options